nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—Cytochrome P450 3A4 Inhibitors—Colchicine—primary biliary cirrhosis	0.766	1	CiPCiCtD
Ticagrelor—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.0544	0.426	CbGbCtD
Ticagrelor—ABCB1—Colchicine—primary biliary cirrhosis	0.0459	0.359	CbGbCtD
Ticagrelor—CYP3A4—Colchicine—primary biliary cirrhosis	0.0275	0.215	CbGbCtD
Ticagrelor—Ulcer haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.0127	0.149	CcSEcCtD
Ticagrelor—Ulcer haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.0127	0.149	CcSEcCtD
Ticagrelor—ABCB1—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00217	0.0997	CbGpPWpGaD
Ticagrelor—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00164	0.0756	CbGpPWpGaD
Ticagrelor—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00134	0.0614	CbGpPWpGaD
Ticagrelor—Lung disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00129	0.0152	CcSEcCtD
Ticagrelor—Lung disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00129	0.0152	CcSEcCtD
Ticagrelor—ABCB1—Abacavir transmembrane transport—ABCG2—primary biliary cirrhosis	0.00112	0.0516	CbGpPWpGaD
Ticagrelor—Oliguria—Colchicine—primary biliary cirrhosis	0.0011	0.013	CcSEcCtD
Ticagrelor—Gout—Colchicine—primary biliary cirrhosis	0.00109	0.0128	CcSEcCtD
Ticagrelor—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00101	0.0466	CbGpPWpGaD
Ticagrelor—Bone disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00101	0.0119	CcSEcCtD
Ticagrelor—Bone disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00101	0.0119	CcSEcCtD
Ticagrelor—ABCB1—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.000906	0.0417	CbGpPWpGaD
Ticagrelor—Melaena—Chenodeoxycholic acid—primary biliary cirrhosis	0.000891	0.0105	CcSEcCtD
Ticagrelor—Melaena—Ursodeoxycholic acid—primary biliary cirrhosis	0.000891	0.0105	CcSEcCtD
Ticagrelor—Ecchymosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000825	0.00974	CcSEcCtD
Ticagrelor—Ecchymosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000825	0.00974	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Colchicine—primary biliary cirrhosis	0.000737	0.0087	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Ursodeoxycholic acid—primary biliary cirrhosis	0.00073	0.00862	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Chenodeoxycholic acid—primary biliary cirrhosis	0.00073	0.00862	CcSEcCtD
Ticagrelor—Atrial fibrillation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000699	0.00825	CcSEcCtD
Ticagrelor—Atrial fibrillation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000699	0.00825	CcSEcCtD
Ticagrelor—Blood creatinine increased—Colchicine—primary biliary cirrhosis	0.000691	0.00815	CcSEcCtD
Ticagrelor—Cardiac failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000679	0.00801	CcSEcCtD
Ticagrelor—Cardiac failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000679	0.00801	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000662	0.00782	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000662	0.00782	CcSEcCtD
Ticagrelor—ABCB1—Abacavir transport and metabolism—ABCG2—primary biliary cirrhosis	0.000645	0.0296	CbGpPWpGaD
Ticagrelor—Blood creatinine increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00062	0.00732	CcSEcCtD
Ticagrelor—Blood creatinine increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00062	0.00732	CcSEcCtD
Ticagrelor—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000598	0.00706	CcSEcCtD
Ticagrelor—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000598	0.00706	CcSEcCtD
Ticagrelor—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000586	0.00692	CcSEcCtD
Ticagrelor—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000586	0.00692	CcSEcCtD
Ticagrelor—CYP3A4—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.000558	0.0257	CbGpPWpGaD
Ticagrelor—Haematuria—Colchicine—primary biliary cirrhosis	0.000542	0.00639	CcSEcCtD
Ticagrelor—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.000496	0.0228	CbGpPWpGaD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—MAS1—primary biliary cirrhosis	0.000493	0.0227	CbGpPWpGaD
Ticagrelor—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000487	0.00574	CcSEcCtD
Ticagrelor—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000487	0.00574	CcSEcCtD
Ticagrelor—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000481	0.00568	CcSEcCtD
Ticagrelor—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000481	0.00568	CcSEcCtD
Ticagrelor—Eye disorder—Colchicine—primary biliary cirrhosis	0.000477	0.00562	CcSEcCtD
Ticagrelor—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000461	0.00543	CcSEcCtD
Ticagrelor—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000461	0.00543	CcSEcCtD
Ticagrelor—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00046	0.00542	CcSEcCtD
Ticagrelor—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000458	0.00541	CcSEcCtD
Ticagrelor—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000458	0.00541	CcSEcCtD
Ticagrelor—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000452	0.00534	CcSEcCtD
Ticagrelor—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000452	0.00534	CcSEcCtD
Ticagrelor—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000451	0.00533	CcSEcCtD
Ticagrelor—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000451	0.00533	CcSEcCtD
Ticagrelor—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00045	0.00531	CcSEcCtD
Ticagrelor—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00045	0.00531	CcSEcCtD
Ticagrelor—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000449	0.0053	CcSEcCtD
Ticagrelor—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000449	0.0053	CcSEcCtD
Ticagrelor—Malnutrition—Colchicine—primary biliary cirrhosis	0.000444	0.00524	CcSEcCtD
Ticagrelor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000434	0.0199	CbGpPWpGaD
Ticagrelor—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000428	0.00505	CcSEcCtD
Ticagrelor—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000428	0.00505	CcSEcCtD
Ticagrelor—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—primary biliary cirrhosis	0.000425	0.0196	CbGpPWpGaD
Ticagrelor—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000425	0.00502	CcSEcCtD
Ticagrelor—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000425	0.00502	CcSEcCtD
Ticagrelor—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000416	0.00491	CcSEcCtD
Ticagrelor—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000416	0.00491	CcSEcCtD
Ticagrelor—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000414	0.00488	CcSEcCtD
Ticagrelor—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000414	0.00488	CcSEcCtD
Ticagrelor—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000413	0.00487	CcSEcCtD
Ticagrelor—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000413	0.00487	CcSEcCtD
Ticagrelor—Angioedema—Colchicine—primary biliary cirrhosis	0.000406	0.00479	CcSEcCtD
Ticagrelor—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000399	0.00471	CcSEcCtD
Ticagrelor—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000399	0.00471	CcSEcCtD
Ticagrelor—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000386	0.00455	CcSEcCtD
Ticagrelor—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000386	0.00455	CcSEcCtD
Ticagrelor—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000364	0.0043	CcSEcCtD
Ticagrelor—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000364	0.0043	CcSEcCtD
Ticagrelor—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.000358	0.00423	CcSEcCtD
Ticagrelor—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.000358	0.00423	CcSEcCtD
Ticagrelor—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000358	0.00422	CcSEcCtD
Ticagrelor—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000358	0.00422	CcSEcCtD
Ticagrelor—CYP3A4—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.000357	0.0164	CbGpPWpGaD
Ticagrelor—Shock—Colchicine—primary biliary cirrhosis	0.000356	0.00421	CcSEcCtD
Ticagrelor—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000355	0.00419	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—CXCR5—primary biliary cirrhosis	0.000354	0.0163	CbGpPWpGaD
Ticagrelor—Skin disorder—Colchicine—primary biliary cirrhosis	0.000352	0.00415	CcSEcCtD
Ticagrelor—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000351	0.00414	CcSEcCtD
Ticagrelor—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000351	0.00414	CcSEcCtD
Ticagrelor—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000348	0.00411	CcSEcCtD
Ticagrelor—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000348	0.00411	CcSEcCtD
Ticagrelor—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000344	0.00406	CcSEcCtD
Ticagrelor—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000344	0.00406	CcSEcCtD
Ticagrelor—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00034	0.00401	CcSEcCtD
Ticagrelor—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00034	0.00401	CcSEcCtD
Ticagrelor—Hypotension—Colchicine—primary biliary cirrhosis	0.000339	0.004	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000337	0.00398	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000337	0.00398	CcSEcCtD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—CXCR5—primary biliary cirrhosis	0.000329	0.0151	CbGpPWpGaD
Ticagrelor—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.000328	0.00387	CcSEcCtD
Ticagrelor—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.000328	0.00387	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—CXCL9—primary biliary cirrhosis	0.000322	0.0148	CbGpPWpGaD
Ticagrelor—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.00032	0.00378	CcSEcCtD
Ticagrelor—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.00032	0.00378	CcSEcCtD
Ticagrelor—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000319	0.00377	CcSEcCtD
Ticagrelor—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000319	0.00377	CcSEcCtD
Ticagrelor—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000316	0.00373	CcSEcCtD
Ticagrelor—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000316	0.00373	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000313	0.00369	CcSEcCtD
Ticagrelor—Fatigue—Colchicine—primary biliary cirrhosis	0.000312	0.00369	CcSEcCtD
Ticagrelor—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.000306	0.014	CbGpPWpGaD
Ticagrelor—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000304	0.00359	CcSEcCtD
Ticagrelor—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000304	0.00359	CcSEcCtD
Ticagrelor—CYP3A4—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.000303	0.014	CbGpPWpGaD
Ticagrelor—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000299	0.0137	CbGpPWpGaD
Ticagrelor—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000296	0.0035	CcSEcCtD
Ticagrelor—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000292	0.00345	CcSEcCtD
Ticagrelor—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000292	0.00345	CcSEcCtD
Ticagrelor—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00029	0.00342	CcSEcCtD
Ticagrelor—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00029	0.00342	CcSEcCtD
Ticagrelor—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00338	CcSEcCtD
Ticagrelor—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00338	CcSEcCtD
Ticagrelor—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000286	0.00338	CcSEcCtD
Ticagrelor—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000285	0.0131	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCR5—primary biliary cirrhosis	0.000282	0.013	CbGpPWpGaD
Ticagrelor—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000281	0.00332	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000281	0.00332	CcSEcCtD
Ticagrelor—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000281	0.00331	CcSEcCtD
Ticagrelor—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000281	0.00331	CcSEcCtD
Ticagrelor—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000278	0.00329	CcSEcCtD
Ticagrelor—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000278	0.00329	CcSEcCtD
Ticagrelor—ABCB1—ABC-family proteins mediated transport—ABCC2—primary biliary cirrhosis	0.000272	0.0125	CbGpPWpGaD
Ticagrelor—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000268	0.00317	CcSEcCtD
Ticagrelor—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000268	0.00317	CcSEcCtD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000267	0.0123	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000267	0.00315	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000266	0.00314	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000266	0.00314	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—RAD51B—primary biliary cirrhosis	0.000263	0.0121	CbGpPWpGaD
Ticagrelor—Asthenia—Colchicine—primary biliary cirrhosis	0.00026	0.00307	CcSEcCtD
Ticagrelor—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000257	0.00304	CcSEcCtD
Ticagrelor—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000257	0.00304	CcSEcCtD
Ticagrelor—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000257	0.00304	CcSEcCtD
Ticagrelor—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000257	0.00304	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL9—primary biliary cirrhosis	0.000256	0.0118	CbGpPWpGaD
Ticagrelor—CYP3A4—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.00025	0.0115	CbGpPWpGaD
Ticagrelor—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000248	0.00293	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—PDE5A—primary biliary cirrhosis	0.000244	0.0112	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00283	CcSEcCtD
Ticagrelor—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00283	CcSEcCtD
Ticagrelor—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000234	0.00276	CcSEcCtD
Ticagrelor—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000234	0.00276	CcSEcCtD
Ticagrelor—Vomiting—Colchicine—primary biliary cirrhosis	0.00023	0.00272	CcSEcCtD
Ticagrelor—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00023	0.00272	CcSEcCtD
Ticagrelor—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00023	0.00272	CcSEcCtD
Ticagrelor—Rash—Colchicine—primary biliary cirrhosis	0.000228	0.0027	CcSEcCtD
Ticagrelor—Dermatitis—Colchicine—primary biliary cirrhosis	0.000228	0.00269	CcSEcCtD
Ticagrelor—Headache—Colchicine—primary biliary cirrhosis	0.000227	0.00268	CcSEcCtD
Ticagrelor—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000223	0.00263	CcSEcCtD
Ticagrelor—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000223	0.00263	CcSEcCtD
Ticagrelor—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000215	0.00254	CcSEcCtD
Ticagrelor—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000215	0.00254	CcSEcCtD
Ticagrelor—Nausea—Colchicine—primary biliary cirrhosis	0.000215	0.00254	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—CXCR5—primary biliary cirrhosis	0.000215	0.00986	CbGpPWpGaD
Ticagrelor—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000207	0.00244	CcSEcCtD
Ticagrelor—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000207	0.00244	CcSEcCtD
Ticagrelor—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000205	0.00242	CcSEcCtD
Ticagrelor—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000205	0.00242	CcSEcCtD
Ticagrelor—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000205	0.00242	CcSEcCtD
Ticagrelor—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000205	0.00242	CcSEcCtD
Ticagrelor—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000204	0.00241	CcSEcCtD
Ticagrelor—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000204	0.00241	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—CXCL9—primary biliary cirrhosis	0.000195	0.00896	CbGpPWpGaD
Ticagrelor—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000193	0.00228	CcSEcCtD
Ticagrelor—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000193	0.00228	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—CXCR5—primary biliary cirrhosis	0.000184	0.00847	CbGpPWpGaD
Ticagrelor—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000184	0.00847	CbGpPWpGaD
Ticagrelor—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—primary biliary cirrhosis	0.000181	0.00831	CbGpPWpGaD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000176	0.00807	CbGpPWpGaD
Ticagrelor—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000174	0.00802	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—CXCL10—primary biliary cirrhosis	0.000168	0.0077	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CXCL9—primary biliary cirrhosis	0.000167	0.0077	CbGpPWpGaD
Ticagrelor—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000166	0.00764	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL12A—primary biliary cirrhosis	0.000163	0.00749	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—primary biliary cirrhosis	0.00016	0.00735	CbGpPWpGaD
Ticagrelor—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.000155	0.00714	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—CCL5—primary biliary cirrhosis	0.000144	0.00663	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—ABCG2—primary biliary cirrhosis	0.000142	0.00655	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	0.000133	0.00613	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	0.000121	0.00557	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—AGT—primary biliary cirrhosis	0.000121	0.00555	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	0.000115	0.00527	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCR5—primary biliary cirrhosis	0.00011	0.00506	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	0.00011	0.00506	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000103	0.00475	CbGpPWpGaD
Ticagrelor—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000102	0.0047	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL12B—primary biliary cirrhosis	0.000102	0.0047	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CXCL10—primary biliary cirrhosis	0.000101	0.00467	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCL9—primary biliary cirrhosis	0.0001	0.0046	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—ALB—primary biliary cirrhosis	9.73e-05	0.00447	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CTLA4—primary biliary cirrhosis	9.61e-05	0.00442	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	9.59e-05	0.00441	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CCL5—primary biliary cirrhosis	8.73e-05	0.00402	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CD40LG—primary biliary cirrhosis	7.48e-05	0.00344	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—AGT—primary biliary cirrhosis	7.31e-05	0.00336	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—HIF1A—primary biliary cirrhosis	7.28e-05	0.00335	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL4—primary biliary cirrhosis	7.27e-05	0.00334	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	7.14e-05	0.00328	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CDH5—primary biliary cirrhosis	6.76e-05	0.00311	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—NOS2—primary biliary cirrhosis	6.62e-05	0.00304	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCR5—primary biliary cirrhosis	6.5e-05	0.00299	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—NOS2—primary biliary cirrhosis	5.97e-05	0.00274	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL9—primary biliary cirrhosis	5.91e-05	0.00272	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	5.73e-05	0.00264	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CD80—primary biliary cirrhosis	5.56e-05	0.00256	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ELMO1—primary biliary cirrhosis	5.46e-05	0.00251	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCL10—primary biliary cirrhosis	5.21e-05	0.00239	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—ALB—primary biliary cirrhosis	5.01e-05	0.00231	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CCL5—primary biliary cirrhosis	4.94e-05	0.00227	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	4.81e-05	0.00221	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—MMP3—primary biliary cirrhosis	4.75e-05	0.00218	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCL5—primary biliary cirrhosis	4.48e-05	0.00206	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—AGT—primary biliary cirrhosis	4.13e-05	0.0019	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—AGT—primary biliary cirrhosis	3.75e-05	0.00172	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—LBR—primary biliary cirrhosis	3.35e-05	0.00154	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL10—primary biliary cirrhosis	3.08e-05	0.00141	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	2.99e-05	0.00138	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	2.97e-05	0.00136	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	2.84e-05	0.00131	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP3—primary biliary cirrhosis	2.81e-05	0.00129	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—TYK2—primary biliary cirrhosis	2.8e-05	0.00129	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL5—primary biliary cirrhosis	2.65e-05	0.00122	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	2.6e-05	0.0012	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	2.57e-05	0.00118	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	2.42e-05	0.00111	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	2.42e-05	0.00111	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.22e-05	0.00102	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—AGT—primary biliary cirrhosis	2.21e-05	0.00102	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	2.16e-05	0.000991	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	2.06e-05	0.000948	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	2.03e-05	0.000932	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	2.03e-05	0.000932	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CD80—primary biliary cirrhosis	1.96e-05	0.000902	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	1.81e-05	0.00083	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TYK2—primary biliary cirrhosis	1.66e-05	0.000762	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	1.49e-05	0.000685	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	1.33e-05	0.000611	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP9—primary biliary cirrhosis	1.3e-05	0.0006	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.29e-05	0.000593	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	1.25e-05	0.000574	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	1.25e-05	0.000574	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	1.22e-05	0.00056	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	1.13e-05	0.000521	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	9.72e-06	0.000447	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	9.63e-06	0.000443	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	9.44e-06	0.000434	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	8.31e-06	0.000382	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	8.31e-06	0.000382	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	7.5e-06	0.000345	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	7.4e-06	0.00034	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	6.98e-06	0.000321	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	5.99e-06	0.000275	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	5.93e-06	0.000273	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—AGT—primary biliary cirrhosis	5.76e-06	0.000265	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	5.12e-06	0.000235	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	5.12e-06	0.000235	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	4.56e-06	0.00021	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALB—primary biliary cirrhosis	4.42e-06	0.000203	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	3.55e-06	0.000163	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	2.72e-06	0.000125	CbGpPWpGaD
